# Roswell Park Cancer Institute Corporation. Div. of Pathology – FDA Inspection, Jun 17, 2011

Source: https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/30483b1c-39cf-4a67-ae27-4da16dda57aa
Source feed: FDA_Inspections

> FDA inspection 730322 of Roswell Park Cancer Institute Corporation. Div. of Pathology, June 17, 2011. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 211 and 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 730322
- Company Name: Roswell Park Cancer Institute Corporation. Div. of Pathology
- Inspection Date: 2011-06-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1284298 - 2025-09-19
- FDA Inspection 1200624 - 2023-03-13
- FDA Inspection 1084076 - 2019-03-01
- FDA Inspection 998259 - 2017-01-13
- FDA Inspection 908088 - 2014-12-19

Company: https://www.keypedia.com/companies/roswell-park-cancer-institute-corporation-div-of-pathology/6e9694cd-483d-4566-97d5-5b1f0c755980

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d